| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d801d0e287951e2704d7101b7ff7918 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y305-01002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-80 |
| filingDate |
1992-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b01a7fc106a443668f2f372c570a589a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a841b0aeb8d216cb5447bd45fcb18b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e7755ec3f12d5a07bd9773a9b63f7a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a30b41dcfc46b47431aaab7c64330df9 |
| publicationDate |
2007-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1854876-A2 |
| titleOfInvention |
Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| abstract |
The invention provides a cell-free preparation of a therapeutically suitable glutaminase which is free of Psuedomonas endotoxin. The glutaminase is preferably free of other Pseudomonas proteins and asparaginase. The glutaminase is useful in treating cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111514460-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111514460-A |
| priorityDate |
1992-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |